Cogstate Ltd. is a global cognitive science company, delivering software and services to optimize the measurement of cognition in clinical trials, academic research, healthcare and brain injury. The company operates through the following segments: Clinical Trials, precision recruitment, healthcare and sport. The Clinical Trials segment includes products and services were sold to pharmaceutical and biotechnology companies to quantify the effect of drugs or other interventions on humans. The precision recruitment segment includes technology is used to recruit patients for clinical drug trials. The healthcare segment includes technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. The Sports segment includes technology and associated services are used to provide concussion management tools in sport as well as skill training for athletes. Cogstate was founded by David Gordon Darby and Paul Maruff on December 17, 1999 and is headquartered in Melbourne, Australia.
|Market Price at 18-01-2018||$0.95|
|Price to Earnings Ratio||-164.22|
|Market Capitalisation||$108.55 (million)|
|Return on Equity (ROE)||-5.49%|